Tijms, Betty M. http://orcid.org/0000-0002-2612-1797
Vromen, Ellen M.
Mjaavatten, Olav
Holstege, Henne http://orcid.org/0000-0002-7688-3087
Reus, Lianne M.
van der Lee, Sven http://orcid.org/0000-0003-1606-8643
Wesenhagen, Kirsten E. J.
Lorenzini, Luigi
Vermunt, Lisa http://orcid.org/0000-0001-7420-6384
Venkatraghavan, Vikram
Tesi, Niccoló http://orcid.org/0000-0002-1413-5091
Tomassen, Jori
den Braber, Anouk
Goossens, Julie
Vanmechelen, Eugeen http://orcid.org/0000-0002-9466-5366
Barkhof, Frederik http://orcid.org/0000-0003-3543-3706
Pijnenburg, Yolande A. L.
van der Flier, Wiesje M. http://orcid.org/0000-0001-8766-6224
Teunissen, Charlotte E. http://orcid.org/0000-0002-4061-0837
Berven, Frode S.
Visser, Pieter Jelle http://orcid.org/0000-0001-8008-9727
Funding for this research was provided by:
ZonMw (733050824)
the Dutch L’Óreal-UNESCO fellowship 2022 for women in science
Article History
Received: 11 September 2023
Accepted: 29 November 2023
First Online: 9 January 2024
Competing interests
: P.J.V. and B.M.T. are coinventors on a patent of CSF proteomic subtypes (published under patent no. US2022196683A1, owner VUmc Foundation). E.V. is cofounder of ADx NeuroSciences, while J.G. is an employee of ADx NeuroSciences. F.B. is on the steering committee or data safety monitoring board for Biogen, Merck, ATRI/ACTC and Prothena. He is a consultant for Roche, Celltrion, Rewind Therapeutics, Merck, IXICO, Jansen and Combinostics. He has research agreements with Merck, Biogen, GE Healthcare and Roche, and he is cofounder and shareholder of Queen Square Analytics LTD. L.V. received consulting fees from Roche and Olink, all paid to Amsterdam UMC. C.E.T. performed contract research for ADx NeuroSciences, AC-Immune, Aribio, Axon Neurosciences, Beckman-Coulter, BioConnect, Bioorchestra, Brainstorm Therapeutics, Celgene, Cognition Therapeutics, EIP Pharma, Eisai, Eli Lilly, Fujirebio, Grifols, Instant Nano Biosensors, Merck, Novo Nordisk, Olink, PeopleBio, Quanterix, Roche, Siemens, Toyama and Vivoryon. She is editor of <i>Alzheimer Research and Therapy</i>, and serves on the editorial boards of <i>Medidact Neurologie/Springer</i> and <i>Neurology: Neuroimmunology & Neuroinflammation</i>. The remaining authors declare no competing interests.